This SuperSeries is composed of the SubSeries listed below.
Overall design: Refer to individual Series
| Accession | PRJNA765317; GEO: GSE184592 |
| Type | Umbrella project |
| Publications | Wellinger LC et al., "BET Inhibition Enhances TNF-Mediated Antitumor Immunity.", Cancer Immunol Res, 2022 Jan;10(1):87-107 |
| Submission | Registration date: 22-Sep-2021
Omar Abdel-Wahab Laboratory, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center |
| Relevance | Superseries |
Project Data:
| Resource Name | Number
of Links |
|---|
| Sequence data |
| SRA Experiments | 41 |
| Publications |
| PubMed | 1 |
| Other datasets |
| BioSample | 41 |
| GEO DataSets | 3 |
BET Inhibition Enhances TNF Mediated Anti-Tumor Immunity encompasses the following 2 sub-projects:
| Project Type | Number of Projects |
| Epigenomics | 1 |
BioProject
accession | Organism | Title |
|---|
| PRJNA765322 | Mus musculus | BET Inhibition Enhances TNF Mediated Anti-Tumor Immunity [ChIP-Seq, ATAC-Seq] (Peter MacCallum Cancer Centre) |
|
| Transcriptome or Gene expression | 1 |
BioProject
accession | Organism | Title |
|---|
| PRJNA765320 | Mus musculus | BET Inhibition Enhances TNF Mediated Anti-Tumor Immunity [RNA-Seq] (Peter MacCallum Cancer Centre) |
|